SmallCap Biotech Stocks Potential Opportunities in a Promising but Volatile Sector EXAS Q4 2025 Earnings Significant EPS Miss Highlights Operational Challenges Osim Founder Ron Sim Drops Legal Claims Against Trek 2000 After Selling Stake at Premium to New Investor